变量

数量

癌胚抗原 (+) N (%)

P value

CA199

(+) N (%)

P value

CA72-4

(+) N (%)

P value

Combined

detection

(+) N (%)

P value

性别:

69

34 (49.2)

18 (26.0)

23 (33.3)

48 (69.5)

21

8 (38)

0.369

5 (23.8)

0.834

9 (42.8)

0.425

15 (71.4)

0.870

年龄(岁):

≤60

34

18 (52.9)

9 (26.4)

14 (41.1)

26 (76.4)

>60

56

24 (42.8)

0.353

14 (25.0)

0.877

18 (32.1)

0.385

37 (66.0)

0.297

分化程度:

分化较好

38

11 (28.9)

7 (18.4)

10 (26.3)

22 (57.8)

分化不良

52

31 (59.6)

0.004

16 (30.7)

0.185

22 (42.3)

0.117

41 (78.8)

0.032

肿瘤直径:

≤4 cm

80

36 (45.0)

22 (27.5)

25 (31.2)

55 (68.7)

>4 cm

10

6 (60)

0.575

1 (10)

0.417

7 (70)

0.039

8 (80)

0.714

浸润深度:

T1 + T2

36

13 (36.1)

6 (16.6)

14 (38.8)

22 (61.1)

T3 + T4

54

29 (53.7)

0.101

17 (31.4)

0.114

18 (33.3)

0.590

41 (75.9)

0.133

淋巴结转移数:

N0 + N1

49

18 (36.7)

10 (20.4)

15 (30.6)

29 (59.1)

N2 + N3

41

24 (58.5)

0.039

13 (31.7)

0.221

17 (41.4)

0.284

34 (82.9)

0.014

TNM分期:

I + II

34

12 (35.2)

5 (14.7)

7 (20.5)

20 (58.8)

III + IV

56

30 (53.5)

0.092

18 (32.1)

0.066

25 (44.6)

0.021

43 (76.7)

0.071

脉管癌栓:

阳性

23

10 (43.4)

5 (21.7)

10 (43.3)

16 (69.5)

阴性

67

32 (47.7)

0.722

18 (26.8)

0.627

22 (32.8)

0.358

47 (70.1)

0.958

神经浸润:

阳性

21

10 (47.6)

9 (42.8)

8 (38.0)

17 (80.9)

阴性

69

32 (46.3)

0.920

14 (20.2)

0.038

24 (34.7)

0.781

46 (66.2)

0.211

肿瘤部位:

胃窦

54

28 (51.8)

15 (27.7)

21 (38.8)

36 (66.6)

胃体 + 胃底

36

14 (38.8)

0.227

8 (22.2)

0.554

11 (30.5)

0.418

27 (75.0)

0.398

化疗疗效:

CR + PR + SD

67

26 (38.8)

17 (25.3)

25 (37.3)

44 (65.6)

PD

23

16 (69.5)

0.011

6 (26.0)

0.946

7 (30.4)

0.552

19 (82.6)

0.126

病理反应:

pCR

7

5 (71.4)

1 (14.2)

2 (28.5)

6 (85.7)

Non-pCR

83

37 (44.5)

0.245

22 (26.5)

0.794

30 (36.1)

1.000

57 (68.6)

0.670